Skip to main content

Find Clinical Trials

Home
Conditions
RAS and BRAF Wild-type

Clinical trial condition

RAS and BRAF Wild-type

Explore clinical trials studying RAS and BRAF Wild-type. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

RAS and BRAF Wild-type trial results

Completed

Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients

NCT04080843

Conditions: Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +10 more
Locations: The Second Affiliated Hospital of Zhejiang University Hangzhou, Zhejiang, China

Zhejiang Cancer Hospital Hangzhou, Zhejiang, China

View Trial Details